Current ACC/AHA guidelines recommend that in patients with stable angina, noninvasive testing is used to prove mild or moderate ischaemia prior to performing PCI. […]
Category: Interventional cardiology
DES show mortality benefit in AMI
Currently both bare metal stents (BMS) and drug-eluting stents (DES) are used during percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). PCI has been demonstrated to reduce the rate of death or recurrent ischaemia when compared to medical therapy. To date trials comparing DES and BMS in acute MI have been limited by small […]
Longer antiplatelet therapy gives good DES outcomes
Recently an excess of acute adverse coronary events has been reported among diabetic patients treated with drug eluting coronary stents (DES) who received short-term (<6 months) dual antiplatelet therapy (Circulation 2007;115:1440-55). […]